CompanyDeals

Taibang Biologic Raises $300M in Post-Privatization Financing Round

CompanyDeals

Sironax Completes $200 Million Series B Financing for Age-Related Disease Therapies

CompanyDeals

ImmVira Partners with China Resources Biopharmaceutical on Oncolytic Virus MVR-C5252 for Gliomas

CompanyDeals

Tus-Pharma to Acquire Sinotau Pharma for RMB 220 Million

CompanyDrug

Eli Lilly Files for Baqsimi Approval in China to Treat Severe Hypoglycemia

CompanyDrug

Aosaikang’s ASKG315 Receives Ethics Approval for Phase I Cancer Trial in Australia

Company

Ablaze Pharma to Invest $100M in Chengdu TRT R&D and Manufacturing Hub

Company

Astellas Pharma Posts 17% Q1 Sales Growth Driven by Xtandi and Padcev

Drug

Eli Lilly’s Taltz Wins Second NMPA Approval for Ankylosing Spondylitis

CompanyDeals

China Resources Double-Crane to Acquire Stake in Shenzhou Biotech for Bio-Fermentation Push

CompanyDeals

Coherent Biopharma Raises Series B Funds to Advance Bi-XDC Pipeline

CompanyDrug

Hengrui Medicine’s Pyrotinib Combo Meets Endpoints in HER2+ Breast Cancer Trial